Artificial intelligence used to detect early-stage heart disease
9 January 2019 | By European Pharmaceutical Review
Mayo study uses artificial intelligence to create inexpensive, widely available early detector of heart disease...
List view / Grid view
heart disease
Raman used to detect post-traumatic stress disorder syndrome
27 July 2018 | By Mike Stones
Raman spectroscopy can help to detect post-traumatic stress disorder syndrome by revealing the levels of stress hormone in human hair.
Procedure plus medication is better than standard treatment for heart disease patients
24 May 2018 | By European Pharmaceutical Review
Percutaneous coronary intervention (PCI), along with prescribed medication, is better than medication alone as initial treatment for people with the most common form of heart disease.
Using AI to detect heart disease
19 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers apply machine learning to create a quick and easy method for measuring changes linked to cardiovascular disease...
Nicotinamide riboside shows promise for reversing cardiovascular ageing
2 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Nicotinamide riboside was shown to mimic caloric restriction, boosting arterial health...
Calcium PET/CT testing in coronary arteries predicts heart attack risk
12 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have found that incorporating imaging technologies more precisely can predict heart attack risk...
3d simulation gives authentic representation of left-hand heart mechanisms
2 March 2018 | By European Pharmaceutical Review
A team of scientists in Italy has developed a 3d model that uniquely presents an holistic demonstration of how the left-hand chambers of the heart interact with blood flow and its component parts. The ultimate aim is better prevention and treatment of cardiac conditions.
NPL launches Metrology for Medical Physics Centre, MEMPHYS
23 February 2018 | By Steve Bremer (European Pharmaceutical Review)
MEMPHYS will work closely with the NHS, academia and industry to enable the rapid and widespread implementation of a host of new diagnostic and therapeutic technologies.
GDM points toward heightened risk of heart disease
17 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Women who have gestational diabetes mellitus during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future...
Scientists develop powerful technique to study the secrets of nanodomains
10 January 2018 | By Drug Target Review
A team of UK scientists have harnessed an innovative new method to gain a greater understanding of signalling stations within living cells, called nanodomains.
Anabolic androgenic steroids associated with early coronary artery disease
6 November 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Tomography coronary angiography used to assess the presence of atherosclerosis associated with anabolic androgenic steroid abuse...
Anacetrapib reduces risk of serious cardiovascular events
29 August 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
An international clinical trial has assessed the efficacy and safety of adding anacetrapib versus placebo atorvastatin in patients with vascular diseases...
Lasers used to detect risk of heart attack and stroke
21 August 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Patients at risk of heart attacks and strokes may be spotted earlier thanks to a diagnosis tool that uses near-infrared light...
Biopharma stages a strong recovery
3 August 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
After the first half of 2017 biopharma investors are in a position to be exuberant, the threat of US price controls that have overshadowed the sector for a year have largely disappeared...
Follow: